白血病·淋巴瘤
白血病·淋巴瘤
백혈병·림파류
JOURNAL OF LEUKEMIA & LYMPHOMA
2012年
4期
218-220,224
,共4页
王列样%赵志强%王艳峰%苏文%郑玉萍
王列樣%趙誌彊%王豔峰%囌文%鄭玉萍
왕렬양%조지강%왕염봉%소문%정옥평
淋巴瘤,非霍奇金%T细胞,调节性
淋巴瘤,非霍奇金%T細胞,調節性
림파류,비곽기금%T세포,조절성
Lymphoma,non-Hodgkin%T-lymphocytes,regulatory
目的 探讨外周血CD+4CDhigh25CDlow127调节性T细胞(Treg细胞)水平与非霍奇金淋巴瘤(NHL)的关系.方法 采用流式细胞术检测123例初治NHL患者、41名健康成年人外周血CD+4CDhigh25CDlow127 Treg水平,并分析其与临床因素的关系.结果 健康成年人外周血CD+4CDhigh25CDlow127 Treg水平中位数为5.0% (四分位数间距为2.7%),初诊NHL患者中位数为7.2%(四分位数间距为3.8%),两者之间差异有统计学意义(Z=-2.816,P=0.001).初诊NHL患者外周血Treg水平在男性患者中中位数为7.2%(四分位数间距为7.4%),在女性患者中中位数为6.1%(四分位数间距为3.8%),差异有统计学意义(Z=- 2.729,P=0.006);乳酸脱氢酶(LDH)增高组中位数为7.8%(四分位数间距为5.9%),LDH正常组中位数为7.0%(四分位数间距为3.3%),差异具有统计学意义(Z=- 2.623,P=0.008);Ⅲ~Ⅳ期患者中位数为7.3%(四分位数间距为53%),Ⅰ ~Ⅱ期患者中位数为5.9%(四分位数间距为3.7%),差异有统计学意义(Z=- 2.057,p=0.04);而NHL患者在不同年龄、IPI评分、结外病变、体能状况、大包块、病理类型、B症状等之间外周血Treg水平差异无统计学意义(均P>0.05).结论 NHL患者体内存在免疫抑制,在男性患者、LDH增高患者及分期为Ⅲ~Ⅳ期患者中CD+4CDhigh25CDlow127 Treg水平明显增高.
目的 探討外週血CD+4CDhigh25CDlow127調節性T細胞(Treg細胞)水平與非霍奇金淋巴瘤(NHL)的關繫.方法 採用流式細胞術檢測123例初治NHL患者、41名健康成年人外週血CD+4CDhigh25CDlow127 Treg水平,併分析其與臨床因素的關繫.結果 健康成年人外週血CD+4CDhigh25CDlow127 Treg水平中位數為5.0% (四分位數間距為2.7%),初診NHL患者中位數為7.2%(四分位數間距為3.8%),兩者之間差異有統計學意義(Z=-2.816,P=0.001).初診NHL患者外週血Treg水平在男性患者中中位數為7.2%(四分位數間距為7.4%),在女性患者中中位數為6.1%(四分位數間距為3.8%),差異有統計學意義(Z=- 2.729,P=0.006);乳痠脫氫酶(LDH)增高組中位數為7.8%(四分位數間距為5.9%),LDH正常組中位數為7.0%(四分位數間距為3.3%),差異具有統計學意義(Z=- 2.623,P=0.008);Ⅲ~Ⅳ期患者中位數為7.3%(四分位數間距為53%),Ⅰ ~Ⅱ期患者中位數為5.9%(四分位數間距為3.7%),差異有統計學意義(Z=- 2.057,p=0.04);而NHL患者在不同年齡、IPI評分、結外病變、體能狀況、大包塊、病理類型、B癥狀等之間外週血Treg水平差異無統計學意義(均P>0.05).結論 NHL患者體內存在免疫抑製,在男性患者、LDH增高患者及分期為Ⅲ~Ⅳ期患者中CD+4CDhigh25CDlow127 Treg水平明顯增高.
목적 탐토외주혈CD+4CDhigh25CDlow127조절성T세포(Treg세포)수평여비곽기금림파류(NHL)적관계.방법 채용류식세포술검측123례초치NHL환자、41명건강성년인외주혈CD+4CDhigh25CDlow127 Treg수평,병분석기여림상인소적관계.결과 건강성년인외주혈CD+4CDhigh25CDlow127 Treg수평중위수위5.0% (사분위수간거위2.7%),초진NHL환자중위수위7.2%(사분위수간거위3.8%),량자지간차이유통계학의의(Z=-2.816,P=0.001).초진NHL환자외주혈Treg수평재남성환자중중위수위7.2%(사분위수간거위7.4%),재녀성환자중중위수위6.1%(사분위수간거위3.8%),차이유통계학의의(Z=- 2.729,P=0.006);유산탈경매(LDH)증고조중위수위7.8%(사분위수간거위5.9%),LDH정상조중위수위7.0%(사분위수간거위3.3%),차이구유통계학의의(Z=- 2.623,P=0.008);Ⅲ~Ⅳ기환자중위수위7.3%(사분위수간거위53%),Ⅰ ~Ⅱ기환자중위수위5.9%(사분위수간거위3.7%),차이유통계학의의(Z=- 2.057,p=0.04);이NHL환자재불동년령、IPI평분、결외병변、체능상황、대포괴、병리류형、B증상등지간외주혈Treg수평차이무통계학의의(균P>0.05).결론 NHL환자체내존재면역억제,재남성환자、LDH증고환자급분기위Ⅲ~Ⅳ기환자중CD+4CDhigh25CDlow127 Treg수평명현증고.
Objective To explore the relationship between CD+4CDhigh25CDlow127 Treg level of peripheral blood and NHL.Methods The level of peripheral blood CD+4CDhigh25CDlow127 Treg of 123 newly diagnosed NHL and 41 healthy adults were test by flow cytometry.Results The average peripheral blood CD+4CDhigh25CDlow127 Treg level were 5.0 % (2.7 %) and 7.2 %(3.8 %) in healthy adults and newly diagnosed NHL patients,respectively.The difference between the two groups was statistically significant(Z=-2.816 P=0.001 ).The peripheral blood Treg level was significantly higher in the male NHL patients than that in the female (7.4% vs 6.1%,Z=- 2.729,P=0.006).The peripheral blood Treg level was significantly higher in elevated LDH patients than that in normal LDH patients(7.8% vs 7.0%,Z=-2.623 P=0.008).The peripheral blood Treg level was significantly higher in stage Ⅲ-Ⅳ patients than that in stage Ⅰ -Ⅱ patients (7.3% vs 5.9%,Z=-2.057 P=0.04). There was no significant relationship between peripheral blood Treg level and age, IPI score,extranodal involvement,performance status,bulky disease,pathologic subtype or B symptom (P >0.05).Conclusions NHL patients are in an immunosuppresive statue.Patients of male,with inreased LDH level or in stage Ⅲ-Ⅳ have higher peripheral blood CD+4CDhigh25CDlow127 Treg level.